Search research articles
Contact Us
Filters
Showing results (101-110 of 246) with videos related to
Page
of 25
Sort By:
Trials
|
September 2, 2020
Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA)
Dalifer Freites-Núñez, Athan Baillet, Luis Rodriguez-Rodriguez, et al.
British Journal of Clinical Pharmacology
|
September 6, 2019
Biosimilar and interchangeable: Inseparable scientific concepts?
Fernando de Mora, Alejandro Balsa, María Cornide-Santos, et al.
Seminars in Arthritis and Rheumatism
|
August 4, 2019
Reduction in antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with prior infliximab or adalimumab secondary failure
Ana Martínez Feito, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, et al.
Clinical Rheumatology
|
November 8, 2018
The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors
Ana Martínez-Feito, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, et al.
Arthritis Research & Therapy
|
April 8, 2010
Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor
Alejandro Balsa, Arancha Cabezón, Gisela Orozco, et al.
International Journal of Environmental Research and Public Health
|
October 14, 2022
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions
Vicente F Gil-Guillen, Alejandro Balsa, Beatriz Bernárdez, et al.
Clinical and Experimental Rheumatology
|
November 15, 2022
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification
Marta Novella-Navarro, Virginia Ruiz-Esquide, Gabriela Torres-Ortiz, et al.
Seminars in Arthritis and Rheumatism
|
October 9, 2023
Teleconsultation in rheumatology: A literature review and opinion paper
Jérôme Avouac, Hubert Marotte, Alejandro Balsa, et al.
Clinical and Experimental Rheumatology
|
May 17, 2022
Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors
Borja Hernández-Breijo, Marta Novella-Navarro, Fernanda Genre, et al.
Rheumatology (Oxford, England)
|
February 6, 2024
Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis
Irene Monjo-Henry, Mariela Uyaguari, Laura Nuño, et al.
Page
of 25
Search research articles
Search
Showing results (101-110 of 246) with videos related to
Sort By:
Page
of 25
Trials
|
September 2, 2020
Efficacy, safety and cost-effectiveness of a web-based platform delivering the results of a biomarker-based predictive model of biotherapy response for rheumatoid arthritis patients: a protocol for a randomized multicenter single-blind active controlled clinical trial (PREDIRA)
Dalifer Freites-Núñez, Athan Baillet, Luis Rodriguez-Rodriguez, et al.
British Journal of Clinical Pharmacology
|
September 6, 2019
Biosimilar and interchangeable: Inseparable scientific concepts?
Fernando de Mora, Alejandro Balsa, María Cornide-Santos, et al.
Seminars in Arthritis and Rheumatism
|
August 4, 2019
Reduction in antidrug antibody levels after switching to rituximab in patients with rheumatoid arthritis with prior infliximab or adalimumab secondary failure
Ana Martínez Feito, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, et al.
Clinical Rheumatology
|
November 8, 2018
The effect of methotrexate versus other disease-modifying anti-rheumatic drugs on serum drug levels and clinical response in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors
Ana Martínez-Feito, Chamaida Plasencia-Rodríguez, Victoria Navarro-Compán, et al.
Arthritis Research & Therapy
|
April 8, 2010
Influence of HLA DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor
Alejandro Balsa, Arancha Cabezón, Gisela Orozco, et al.
International Journal of Environmental Research and Public Health
|
October 14, 2022
Medication Non-Adherence in Rheumatology, Oncology and Cardiology: A Review of the Literature of Risk Factors and Potential Interventions
Vicente F Gil-Guillen, Alejandro Balsa, Beatriz Bernárdez, et al.
Clinical and Experimental Rheumatology
|
November 15, 2022
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification
Marta Novella-Navarro, Virginia Ruiz-Esquide, Gabriela Torres-Ortiz, et al.
Seminars in Arthritis and Rheumatism
|
October 9, 2023
Teleconsultation in rheumatology: A literature review and opinion paper
Jérôme Avouac, Hubert Marotte, Alejandro Balsa, et al.
Clinical and Experimental Rheumatology
|
May 17, 2022
Serum leptin concentration is associated with the attainment of clinical outcomes in patients with axial spondyloarthritis treated with TNF inhibitors
Borja Hernández-Breijo, Marta Novella-Navarro, Fernanda Genre, et al.
Rheumatology (Oxford, England)
|
February 6, 2024
Circulating Tfh cells are differentially modified by abatacept or TNF blockers and predict treatment response in rheumatoid arthritis
Irene Monjo-Henry, Mariela Uyaguari, Laura Nuño, et al.
Page
of 25